Viewing Study NCT07478133


Ignite Creation Date: 2026-03-26 @ 3:19 PM
Ignite Modification Date: 2026-04-05 @ 11:32 AM
Study NCT ID: NCT07478133
Status: COMPLETED
Last Update Posted: 2026-03-17
First Post: 2026-03-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence Study of Nalfurafine Hydrochloride Orally Disintegrating Tablets on Fasting and Fed in Humans
Sponsor: Shandong New Time Pharmaceutical Co., LTD
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-05-24
Start Date Type: ACTUAL
Primary Completion Date: 2023-07-14
Primary Completion Date Type: ACTUAL
Completion Date: 2023-07-14
Completion Date Type: ACTUAL
First Submit Date: 2026-03-12
First Submit QC Date: None
Study First Post Date: 2026-03-17
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2026-03-12
Last Update Post Date: 2026-03-17
Last Update Post Date Type: ACTUAL